Red Light Before Implantation Primes Stem Cell Mitochondria to Rebuild Tracheal Cartilage

A simple beam of red light may be able to do what growth factors and genetic engineering have long struggled to achieve: prepare stem cells, in advance, to rebuild one of the most mechanically demanding structures in the human body. In a study published in Materials Today Bio, researchers report that preconditioning bone marrow-derived mesenchymal stem cells (BMSCs) with 660-nanometer LED irradiation reprograms the cells’ mitochondrial machinery, driving them into a regenerative state that dramatically improves tracheal cartilage repair in rabbits. The work offers a striking demonstration that light itself can act as a programming signal for cell fate, and it does so without drugs, without viral vectors, and without leaving any residual chemicals inside the engineered tissue.

The central challenge the team set out to address is a familiar one in regenerative medicine. Stem cells delivered into a defect are often metabolically unprepared for the hostile environment they encounter, remaining incompletely committed to the correct lineage and vulnerable to inflammatory and mechanical stress. Cartilage repair is especially unforgiving, because success requires not just cell survival but stable activation of a chondrogenic program, rich deposition of type II collagen and aggrecan, and active suppression of the fibrotic, hypertrophic and matrix-degrading pathways that cause engineered tissue to fail. Conventional approaches rely on biochemical cues such as transforming growth factor-β, which can switch on chondrogenic genes but provide little control over the intracellular metabolic state that must sustain durable matrix production over time.

The researchers’ strategy targets mitochondria, which have increasingly been recognized not as passive power plants but as active arbiters of stem-cell destiny. Mitochondrial membrane potential, respiratory activity, ATP availability and redox tone collectively determine whether a stem cell is merely alive or genuinely competent to regenerate tissue. Red light around 660 nanometers is absorbed by mitochondrial photoacceptors, most notably cytochrome c oxidase, also known as respiratory complex IV, linking photon input directly to electron transport, ATP synthesis and redox signaling. Unlike soluble biochemical factors, light can be applied externally, withdrawn instantly and spatially controlled, making it an attractive tool for preconditioning cells before they are ever placed inside a patient.

To find the right dose, the team systematically tested 5, 15 and 30 joules per square centimeter of 660-nanometer LED light on rabbit BMSCs, using a power density of 50 milliwatts per square centimeter and carefully monitoring culture temperature with infrared thermal imaging to rule out nonspecific heating. The results revealed a classic biphasic dose-response. At 15 joules per square centimeter, the cells proliferated most vigorously, showed increased S-phase entry by flow cytometry, and maintained high viability. The lowest dose produced only a modest effect, while the highest dose failed to enhance proliferation further and actually reduced cellular activity. Notably, a temperature-matched control group that experienced the same warming without light did not reproduce the inhibition seen at the high dose, indicating that the effect was photobiological rather than thermal.

The critical question was whether this proliferative boost translated into genuine chondrogenic commitment. When BMSCs were formed into cartilage pellets and irradiated daily for 14 days, the 15-joule group produced pellets that were larger, more regular and more compact than any other group. Histological staining showed denser tissue organization and stronger proteoglycan deposition, and biochemical assays confirmed elevated total collagen, type II collagen and glycosaminoglycan content. Crucially, when matrix production was normalized to DNA content, the ratios remained highest in the irradiated group, demonstrating that light enhanced the biosynthetic output of each cell rather than simply expanding the cell population. Western blotting revealed increased SOX9, type II collagen and aggrecan, while the unwanted markers COL1A1, COL10A1, RUNX2 and MMP13, which signal fibrosis, hypertrophy and matrix degradation, were all reduced at both protein and mRNA levels.

The mechanistic heart of the study lies in its dissection of the mitochondrial signaling cascade. At the optimal dose, LED irradiation elevated mitochondrial membrane potential, produced a more interconnected mitochondrial network, increased ATP production and enhanced respiratory parameters including basal respiration, ATP-linked respiration, maximal respiration and spare respiratory capacity, as measured by Seahorse extracellular flux analysis. Cytochrome c oxidase activity was also increased. Perhaps most intriguingly, the treatment induced a moderate rise in mitochondrial hydrogen peroxide, a controlled burst of reactive oxygen species that appears to function as a signaling mediator rather than a damaging by-product. At 30 joules per square centimeter, by contrast, ROS accumulation became excessive, accompanied by elevated malondialdehyde and 4-hydroxynonenal, hallmarks of oxidative stress and lipid peroxidation.

Using a panel of pharmacological inhibitors, the researchers traced the pathway from mitochondria to the nucleus. Scavenging ROS with N-acetyl-L-cysteine attenuated the phosphorylation of PI3K, Akt, mTOR and GSK3β, placing moderate mitochondrial ROS upstream of the cascade. Inhibiting PI3K with LY294002 or Akt with MK-2206 suppressed downstream phosphorylation and reduced SOX9, type II collagen and aggrecan expression, while the mTOR inhibitor rapamycin blunted glycosaminoglycan deposition. The enhanced inhibitory phosphorylation of GSK3β, which reduces its negative regulatory activity, further supported SOX9 nuclear activation, confirmed by immunofluorescence showing stronger nuclear SOX9 signal in irradiated cells. Together, these experiments establish the PI3K/Akt/mTOR/GSK3β–SOX9 axis as the conduit through which photonic energy is converted into a chondrogenic transcriptional program.

The team then translated the optimized treatment into a tissue-engineering construct. Egg white-derived biomaterial was fabricated into ring-shaped porous scaffolds, seeded with BMSCs and irradiated for 14 days before implantation into a rabbit tracheal defect created by resecting one native cartilage ring. At 30 days after surgery, bronchoscopic evaluation showed higher airway patency, reduced granulation formation, lower stenosis and less collapse in the 15-joule group compared with untreated and high-dose controls. Histology revealed organized, proteoglycan-rich cartilage-like matrix, and biochemical analysis showed markedly increased GAG/DNA and COL II/DNA levels that approached, though did not fully reach, those of native tracheal tissue. Fibrotic, hypertrophic and matrix-degrading markers were suppressed in vivo, and epithelial repair was improved, with restored basal coverage and ciliated differentiation alongside reduced injury-associated mucus-producing remodeling.

Most compellingly, direct mechanical benchmarking against native trachea showed that the reconstructed rings in the 15-joule group exhibited higher radial compression modulus, greater anti-collapse pressure, improved bending recovery and lower residual deformation than the other groups, with all four parameters shifting toward the native range. The trachea depends on its cartilage rings to resist collapse during every breath, so restoring load-bearing function is the ultimate test of any repair strategy. The irradiated constructs also resisted osteogenic drift, showing no increase in osteocalcin at the optimized dose, while the high-dose group did, reinforcing the importance of precise photonic dosing. The researchers caution that the 30-day observation period was short, that a temperature-matched control specifically matching the 15-joule condition was not included, and that genetic approaches would further strengthen causal interpretation of the signaling pathway.

What distinguishes this work from earlier photobiomodulation studies is its conceptual shift. Previous efforts applied light directly to injured tissues to modulate the local repair environment; here, light is used before implantation to write a regenerative metabolic state into the cells themselves. The 15-joule condition represents a functional window that coordinates mitochondrial activation with cellular adaptation, highlighting that the goal is not maximal ROS production but a favorable bioenergetic-redox balance. The treatment also showed immunomodulatory promise, shifting macrophages from an inflammatory M1-like phenotype toward a reparative M2-like state and preserving chondrogenic gene expression under interleukin-1β challenge, a scenario that mirrors the inflammatory milieu of real wounds. If the approach can be adapted to larger animal models and clinically relevant reconstruction scenarios, externally controlled, growth factor-sparing photonic preconditioning could become a practical and elegant tool for engineering cartilage that not only fills a defect but performs the mechanical work the body demands of it.

Subject of Research: 660 nm LED mitochondrial preconditioning of bone marrow-derived mesenchymal stem cells for functional tracheal cartilage regeneration

Article Title: 660 nm LED preconditioning programs mitochondrial signaling in BMSCs for functional tracheal cartilage regeneration

Article References: An, Z., Zhang, J., Wang, C., She, Y., Xu, Y., Zhou, H., Xia, J., Guo, L., Ma, M., & Zhang, L. (2026). 660 nm LED preconditioning programs mitochondrial signaling in BMSCs for functional tracheal cartilage regeneration. Materials Today Bio, 41, Article 103729. https://doi.org/10.1016/j.mtbio.2026.103729

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103729

Keywords: photobiomodulation, 660 nm LED, mesenchymal stem cells, mitochondria, chondrogenesis, tracheal cartilage, tissue engineering, SOX9, PI3K/Akt/mTOR signaling, reactive oxygen species, cytochrome c oxidase, scaffold